Watanabe Yoshiki, Tanaka Shinzo, Hiratsuka Yasuyuki, Yamazaki Hiroshi, Yoshida Takao, Kusano Junko, Morita Isao, Matsunaga Momoko, Kitano Masayuki, Yamaguchi Tomoya
a Otolaryngology-Head & Neck Surgery , Osaka Red Cross Hospital , Osaka , Japan.
Acta Otolaryngol. 2019 Feb;139(2):187-194. doi: 10.1080/00016489.2018.1532106. Epub 2019 Feb 21.
Endoscopic laryngo-pharyngeal surgery (ELPS), which is a transoral minimally invasive surgery using a gastrointestinal endoscope and a curved laryngopharyngeal retractor, is effective to treat primary lesions of superficial laryngopharyngeal cancers. To extend concepts of ELPS to invasive laryngopharyngeal cancers, we developed end-flexible-rigidscopic transoral surgery (E-TOS) from ELPS by changing a gastrointestinal endoscope to a flexible-tip rigid endoscope.
AIMS/OBJECTIVES: To retrospectively evaluate oncological outcomes and laryngopharyngeal functional preservation of E-TOS in patients with T1-selected T3 laryngopharyngeal cancers.
In 47 patients T1-selected T3 pharyngeal and supraglottic cancers were resected by E-TOS using the flexible-tip rigid endoscope and curved instruments. Negative resection margin was histopathologically evaluated. The survival, preservation of larynx, and disease control rates were estimated using Kaplan-Meier method.
Curative resection was achieved in 94% of patients. No patient complained prolonged swallowing dysfunction or hoarseness after E-TOS. Postoperative bleeding, stenosis of the pharynx and esophageal entrance, and local recurrence was observed each in one patient. The 3-year overall survival, disease-specific survival, laryngeal preservation, local control, and locoregional control rates were, 86%, 93%, 100%, 98%, and 79%, respectively.
E-TOS is an effective minimally invasive surgery for T1-selected T3 pharyngeal and supraglottic cancers with preserving laryngeal function.
内镜下咽-喉手术(ELPS)是一种使用胃肠内镜和弯曲的下咽牵开器的经口微创手术,对治疗浅表性下咽癌的原发灶有效。为了将ELPS的概念扩展到浸润性下咽癌,我们通过将胃肠内镜换成柔性尖端硬质内镜,从ELPS发展出了可弯曲硬质内镜经口手术(E-TOS)。
回顾性评估E-TOS治疗T1至T3期下咽癌患者的肿瘤学结局和下咽功能保留情况。
47例T1至T3期下咽和声门上癌患者接受了E-TOS手术,使用柔性尖端硬质内镜和弯曲器械进行切除。通过组织病理学评估切缘阴性情况。采用Kaplan-Meier法估计生存率、喉保留率和疾病控制率。
94%的患者实现了根治性切除。E-TOS术后没有患者抱怨长期吞咽功能障碍或声音嘶哑。分别有1例患者出现术后出血、下咽和食管入口狭窄以及局部复发。3年总生存率分别为86%,疾病特异性生存率为93%,喉保留率为100%,局部控制率为98%,区域控制率为79%。
E-TOS是一种有效的微创手术,用于治疗T1至T3期下咽和声门上癌,可保留喉功能。